The AngII level is predicted to increase by approximately 15% for patients with moderate and severe COVID-19 (Table 4); this prediction is in very good agreement with the experimental value of 16% found in [68], but in poorer agreement with the value of 35% resulting from a study of only 12 patients [69]. The gene discussed is AGT; the disease is COVID-19.